PROCEPT BioRobotics Corp (PRCT)
60.62
+7.68
(+14.51%)
USD |
NASDAQ |
May 01, 16:00
61.00
+0.38
(+0.63%)
After-Hours: 20:00
PROCEPT BioRobotics Cash from Operations (TTM): -108.00M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -108.00M |
| September 30, 2023 | -108.38M |
| June 30, 2023 | -109.29M |
| March 31, 2023 | -98.08M |
| December 31, 2022 | -80.38M |
| Date | Value |
|---|---|
| September 30, 2022 | -71.68M |
| June 30, 2022 | -64.58M |
| March 31, 2022 | -60.37M |
| December 31, 2021 | -57.33M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-109.29M
Minimum
Jun 2023
-57.33M
Maximum
Dec 2021
-84.23M
Average
-80.38M
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
| Globus Medical Inc | 243.50M |
| Glaukos Corp | -57.76M |
| Integra Lifesciences Holdings Corp | 139.96M |
| Intuitive Surgical Inc | 1.708B |
| Masimo Corp | 94.10M |